Vivo Bio Tech Ltd. Share Price & Stock Analysis

Vivo Bio Tech Ltd. (BSE: 511509) is a Hyderabad, Telangana-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹37 Cr, it ranks #4,012 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 10 in Life Sciences Tools and Services. At ₹14.77 (as of 19 Nov 2026), the share price is 27.7% below its 52-week high of ₹20.44 and 23.1% above its 52-week low of ₹12.00. The share price is down 55.7% over one year and down 24.8% over three months.

Key Metrics

Current Price₹14.77
Market Cap₹37 Cr
BSE Code511509
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services
Sub-IndustryLife Sciences Tools and Services
P/E RatioNot meaningful (loss)
Return on Equity-2.00%
Return on Assets4.21%
52-Week Range₹12.00 – ₹20.44
1-Year Price Change-55.7%
3-Month Price Change-24.8%
Beta (1Y)0.6
HeadquartersHyderabad, Telangana
Websitewww.vivobio.com

Latest Quarterly Results — Q1 FY27

Revenue₹14 Cr
Net Profit₹0 Cr
Net Margin1.3%
EPS (Basic)₹0.08
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Vivo Bio Tech Ltd. Quarterly Revenue and Profit Trend

Vivo Bio Tech Ltd. reported revenue of ₹14 Cr in Q1 FY27, up 13.8% from ₹12 Cr in Q1 FY26 and up 2.7% from ₹14 Cr in Q4 FY26. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹1 Cr in Q1 FY26 (down 86.9%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹12 Cr (Q4 FY25) to ₹14 Cr (Q1 FY27). The company reported a net loss in 1 of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹14 Cr₹0 Cr1.3%
Q4 FY26₹14 Cr−₹5 Cr−39.5%
Q3 FY26₹13 Cr₹1 Cr9.4%
Q2 FY26₹13 Cr₹1 Cr6.7%
Q1 FY26₹12 Cr₹1 Cr11.0%
Q4 FY25₹12 Cr₹1 Cr9.7%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Delivery averaged 78.8% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).

About Vivo Bio Tech Ltd.

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents’ evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.

Products and Services

1. Bio Technology-This segment provides drug development and discovery services to pharmaceutical and biotech companies. It offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, etc.

Business Segments

1. Bio Technology-100%

Vivo Bio Tech Ltd. vs Peers — Life Sciences Tools and Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Indegene Ltd₹14,840 Cr40.213.94%₹1,122 Cr+26.1%
Suven Life Sciences Ltd.₹7,951 Crn/m-78.80%₹1 Cr+51.8%
Vimta Labs Ltd₹2,259 Cr29.518.55%₹112 Cr-26.8%
Tarsons Products Limited₹1,730 Cr114.92.26%₹124 Cr+25.7%
Brooks Laboratories Ltd.₹198 Cr7.922.28%₹19 Cr-34.2%
Bilcare Ltd.₹194 Cr108.3-5.21%——
Jeevan Scientific Technology Ltd₹176 Cr129.41.68%—+42.3%
Vivo Bio Tech Ltd.₹37 Crn/m-2.00%₹14 Cr-55.7%
Dr. Habeebbullal Life Sciences Ltd₹26 Crn/m-68.79%—-45.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vivo Bio Tech Ltd.?

Vivo Bio Tech Ltd. is trading at ₹14.77, with a market capitalisation of ₹37 Cr.

Which sector does Vivo Bio Tech Ltd. belong to?

Vivo Bio Tech Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).

What are the key financial ratios of Vivo Bio Tech Ltd.?

Vivo Bio Tech Ltd. has a return on equity of -2.00%.

What is the stock symbol of Vivo Bio Tech Ltd.?

Vivo Bio Tech Ltd. is listed on the BSE under the scrip code 511509.

How has Vivo Bio Tech Ltd.'s share price moved over the past year?

Vivo Bio Tech Ltd.'s share price is down 55.7% over one year and down 24.8% over three months. Its 52-week range is ₹12.00 to ₹20.44.

What were Vivo Bio Tech Ltd.'s latest quarterly results?

In Q1 FY27, Vivo Bio Tech Ltd. reported revenue of ₹14 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.08 (standalone, parsed from the company's exchange filing).

How have Vivo Bio Tech Ltd.'s revenue and profit changed over the past year?

Vivo Bio Tech Ltd. reported revenue of ₹14 Cr in Q1 FY27, up 13.8% from ₹12 Cr in Q1 FY26 and up 2.7% from ₹14 Cr in Q4 FY26.

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.